ETON
Eton Pharmaceuticals Inc

5,609
Mkt Cap
$451.07M
Volume
286,264.00
52W High
$23.00
52W Low
$10.20
PE Ratio
-67.52
ETON Fundamentals
Price
$16.30
Prev Close
$16.82
Open
$16.78
50D MA
$18.74
Beta
0.77
Avg. Volume
256,008.61
EPS (Annual)
-$0.1476
P/B
19.50
Rev/Employee
$1.26M
Loading...
Loading...
News
all
press releases
Eton Pharmaceuticals (NASDAQ:ETON) Stock Rating Lowered by Zacks Research
Zacks Research lowered shares of Eton Pharmaceuticals from a "hold" rating to a "strong sell" rating in a report on Thursday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Eton Pharmaceuticals (NASDAQ:ETON) Issues Quarterly Earnings Results, Misses Estimates By $0.20 EPS
Eton Pharmaceuticals (NASDAQ:ETON - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus...
MarketBeat·11d ago
News Placeholder
Anchor Capital Advisors LLC Has $1.25 Million Stock Holdings in Eton Pharmaceuticals, Inc. $ETON
Anchor Capital Advisors LLC grew its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) by 45.7% in the 2nd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·14d ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -153.85% and +9.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Investors need to pay close attention to ETON stock based on the movements in the options market lately.
Zacks·2mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -900.00% and +13.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Eton Pharmaceuticals (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·4mo ago
News Placeholder
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks·6mo ago
News Placeholder
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Zacks·6mo ago
News Placeholder
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
chainwire·7mo ago

Latest ETON News

View

Advertisement|Remove ads.

Advertisement|Remove ads.